Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

by Eric Fox, Thomas Oliver, Melissa Rowe, Sunil Thomas, Yousef Zakharia, Paul B. Gilman, Paul B. Gilman, Alexander J. Muller, Alexander J. Muller, George C. Prendergast, George C. Prendergast
Published 2018-09-01

The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1

by Hollie E. Flick, Judith M. LaLonde, William P. Malachowski, Alexander J. Muller
Published 2013-01-01

The Tumor-Selective Cytotoxic Agent ß-Lapachone is a Potent Inhibitor of IDO1

by Hollie E. Flick, Judith M. LaLonde, William P. Malachowski, Alexander J. Muller
Published 2013-08-01

IDO2 in immunomodulation and autoimmunity

by George ePrendergast, Richard eMetz, Alexander J. Muller, Lauren M.F. Merlo, Laura eMandik-Nayak
Published 2014-11-01

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses

by Lauren M. F. Merlo, James B. DuHadaway, James D. Montgomery, Wei-Dan Peng, Peter J. Murray, George C. Prendergast, George C. Prendergast, George C. Prendergast, Andrew J. Caton, Alexander J. Muller, Laura Mandik-Nayak
Published 2020-08-01

Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

by Mads Hald Andersen, Souvik Dey, Erika Sutanto-Ward, Katharina L Kopp, James DuHadaway, Arpita Mondal, Dema Ghaban, Inés Lecoq, Mai-Britt Zocca, Lauren M F Merlo, Laura Mandik-Nayak, Ayako Wakatsuki Pedersen, Alexander J Muller
Published 2020-07-01